[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Women's Health Market Study 2015-2025, by Segment (Hormonal Treatment, Non-Hormonal Treatment), by Market (Osteoporosis, ContraceptiveNon-Hormonal Treatment, Hypothyroidism), by Company (Merck & Co., Inc., Eli Lilly and Company, Novartis AG)

October 2018 | 68 pages | ID: GCB49EF74C1EN
99Strategy

US$ 1,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Snapshot

The global Women's Health market will reach xxx Million USD in 2018 and with a CAGR if xx% between 2019-2025.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
  • Hormonal Treatment
  • Non-Hormonal Treatment
Demand Coverage (Market Size & Forecast, Consumer Distribution):
  • Osteoporosis
  • Contraceptive
  • Hypothyroidism
  • Uterine Fibroid
  • Urinary Tract Infection
  • Post-Menopausal Syndrome
  • Others
Company Coverage (Sales data, Main Products & Services etc.):
  • Merck & Co., Inc.
  • Eli Lilly and Company
  • Novartis AG
  • Pfizer, Inc.
  • Novo Nordisk A/S
  • Bayer AG
  • Amgen Inc.
  • Lupin Pharmaceuticals, Inc.
  • Sanofi
  • Allergan Plc
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • AstraZeneca
  • F. Hoffmann-La Roche Ltd.
Major Region Market
  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa
1 INDUSTRY OVERVIEW

1.1 Women's Health Industry
  1.1.1 Overview
  1.1.2 Products of Major Companies
1.2 Market Segment
  1.2.1 Industry Chain
  1.2.2 Consumer Distribution
1.3 Price & Cost Overview

2 WOMEN'S HEALTH MARKET BY TYPE

2.1 By Type
  2.1.1 Hormonal Treatment
  2.1.2 Non-Hormonal Treatment
2.2 Market Size by Type
2.3 Market Forecast by Type

3 GLOBAL MARKET DEMAND

3.1 Segment Overview
  3.1.1 Osteoporosis
  3.1.2 Contraceptive
  3.1.3 Hypothyroidism
  3.1.4 Uterine Fibroid
  3.1.5 Urinary Tract Infection
  3.1.6 Post-Menopausal Syndrome
  3.1.7 Others
3.2 Market Size by Demand
3.3 Market Forecast by Demand

4 MAJOR REGION MARKET

4.1 Global Market Overview
  4.1.1 Market Size & Growth
  4.1.2 Market Forecast
4.2 Major Region
  4.2.1 Market Size & Growth
  4.2.2 Market Forecast

5 MAJOR COMPANIES LIST

5.1 Merck & Co., Inc. (Company Profile, Sales Data etc.)
5.2 Eli Lilly and Company (Company Profile, Sales Data etc.)
5.3 Novartis AG (Company Profile, Sales Data etc.)
5.4 Pfizer, Inc. (Company Profile, Sales Data etc.)
5.5 Novo Nordisk A/S (Company Profile, Sales Data etc.)
5.6 Bayer AG (Company Profile, Sales Data etc.)
5.7 Amgen Inc. (Company Profile, Sales Data etc.)
5.8 Lupin Pharmaceuticals, Inc. (Company Profile, Sales Data etc.)
5.9 Sanofi (Company Profile, Sales Data etc.)
5.10 Allergan Plc (Company Profile, Sales Data etc.)
5.11 GlaxoSmithKline plc (Company Profile, Sales Data etc.)
5.12 Johnson & Johnson (Company Profile, Sales Data etc.)
5.13 AstraZeneca (Company Profile, Sales Data etc.)
5.14 F. Hoffmann-La Roche Ltd. (Company Profile, Sales Data etc.)

6 CONCLUSION

LIST OF TABLES

Table GLOBAL WOMEN'S HEALTH MARKET 2015-2018, BY TYPE, IN USD MILLION
Table Global Women's Health Market 2015-2018, by Type, in Volume
Table Global Women's Health Market Forecast 2019-2025, by Type, in USD Million
Table Global Women's Health Market Forecast 2019-2025, by Type, in Volume
Table Merck & Co., Inc. Overview List
Table Women's Health Business Operation of Merck & Co., Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eli Lilly and Company Overview List
Table Women's Health Business Operation of Eli Lilly and Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis AG Overview List
Table Women's Health Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer, Inc. Overview List
Table Women's Health Business Operation of Pfizer, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novo Nordisk A/S Overview List
Table Women's Health Business Operation of Novo Nordisk A/S (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bayer AG Overview List
Table Women's Health Business Operation of Bayer AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Amgen Inc. Overview List
Table Women's Health Business Operation of Amgen Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Lupin Pharmaceuticals, Inc. Overview List
Table Women's Health Business Operation of Lupin Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi Overview List
Table Women's Health Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Allergan Plc Overview List
Table Women's Health Business Operation of Allergan Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline plc Overview List
Table Women's Health Business Operation of GlaxoSmithKline plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Johnson & Johnson Overview List
Table Women's Health Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AstraZeneca Overview List
Table Women's Health Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table F. Hoffmann-La Roche Ltd. Overview List
Table Women's Health Business Operation of F. Hoffmann-La Roche Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

LIST OF FIGURES

Figure Global Women's Health Market Growth 2015-2018, by Type, in USD Million
Figure Global Women's Health Market Growth 2015-2018, by Type, in Volume


More Publications